CBM email header v1
 

Please feel free to forward to colleagues and fellow researchers and share news of our journal

CBM 11

Indexed in: PubMed/MEDLINE Web of Science Scopus

NEW ISSUE

Dear Colleague,

We are delighted to announce the publication of a new issue of the journal Cancer Biomarkers (CBM).

A selection of content from the latest issue is included below, as well as highlights of the most read recent content and details of how to submit your research to the journal.

Looking forward to working with you.

Kind regards,

Editor-in-Chief
Sudhir Srivastava, PhD, MPH
submissions@iospress.com

CBM red-bar

Volume 27, Issue 4 / 2020 Available Online

MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer
Zhang, Jingwei | Kong, Xia | Shi, Qizhu | Zhao, Bin

ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis
Lei, Ren | Feng, Liuchun | Hong, Deng

Novel somatic alterations underlie Chinese papillary thyroid carcinoma
Yang, Chuanjia | Xu, Weixue | Gong, Jian | Liu, Zhen | Cui, Dongxu

STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells
Wu, Jiao | Li, Yi-Tian | Tian, Xiao-Ting | Liu, Yu-Si | Wu, Mo-Li | Li, Pei-Nan | Liu, Jia

MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα
Yu, Ting | Gong, Li | Li, Wei | Zuo, Qianfei | Cai, Dongping | Mao, Hui | Wang, Lina | Lin, Jie | Xiao, Bin

Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer
Zhang, Weijia | Su, Xiaoyan | Li, Shuang | Liu, Zhen | Wang, Qian | Zeng, Hai

LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression
Cai, Xianguo | Zhang, Xianjun | Mo, Licai | Zhu, Jialiang | Yu, Hongyuan

Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis
Kong, Junjie | Shen, Shu | Zhang, Zifei | Wang, Wentao

Low OCEL1 expression is associated with poor prognosis in human non-small cell lung cancer
Deng, Mingming | Zhang, Zhe | Liu, Bofang | Lv, Qingjie | Hou, Kezuo | Che, Xiaofang | Qu, Xiujuan | Liu, Yunpeng | Zhang, Ye | Hu, Xuejun

Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations
Geng, Hua | Li, Shixiong | Guo, Yixian | Yan, Fang | Han, Yuebin | Xu, Meilin | Cui, Yanzhi

CBM red-bar

Most Read Cancer Biomarker Articles in March 2020

Listing articles published only 2020 so you can read the most popular recent content

The interactome of the prostate-specific protein Anoctamin 7 (Research Article in pre-press, 2020) – Open Access
Kaikkonen, Elina | Takala, Aliisa | Pursiheimo, Juha-Pekka | Wahlström, Gudrun | Schleutker, Johanna

A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma (Research Article in pre-press, 2020)
Wang, Zhichao | Cheng, Huiyan | Xu, Huali | Yu, Xiaofeng | Sui, Dayun

FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women (Research Article in Vol.27, Iss.3, 2020) – Open Access
Yang, Fan | Cui, Zifeng | Liao, Yuandong | Tian, Rui | Fan, Weiwen | Jin, Zhuang | Hu, Zheng | Yao, Shuzhong

Identification of key long non-coding RNAs in gastric adenocarcinoma (Research Article in Vol.27, Iss.4, 2020)
Fu, Tao | Ji, Xin | Bu, Zhaode | Zhang, Ji | Wu, Xiaojiang | Zong, Xianglong | Fan, Biao | Jia, Ziyu | Ji, Jiafu

The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma (Research Article in Vol.27, Iss.2, 2020) – Open Access
Ye, Shuang | Liu, Shuai | Zhou, Shuling | Xiang, Libing | Wu, Xiaohua | Yang, Huijuan

Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma (Research Article in Vol.27, Iss.1, 2020) – Open Access
Saman, S. | Stagno, M.J. | Warmann, S.W. | Malek, N.P. | Plentz, R.R. | Schmid, E.

CBM red-bar

Call For Papers

Publish Where Your Work Will Be Noticed

CBM-submit visual 2019-IF v2

Submit Today!

As a member of our research community, we would like to invite you to contribute your own articles to the journal.

There are many benefits for contributing authors, including rigorous peer review and rapid processing and online publication (pre-press), and an affordable open access option.

Submit your manuscript online
View the Instructions for Authors
View list of Editorial Board
View full journal contents

CBM red-bar

Please Share Cancer Biomarker News With Your Colleagues

Help Spread News of CBM!

If you know of any colleagues or fellow researchers who are not yet signed up to receive news from Cancer Biomarkers, we invite you to share this mailing with them.

Click on the visual or access the sign-up link here.

CBM red-bar
***

You are receiving this mailing as you are signed up to receive news from CBM.
You can unsubscribe or alter your preferences at any time by clicking the links below
.

 
 
Powered by Mad Mimi®A GoDaddy® company